Nutritional Strategies to Optimize Outcomes among Infants with Congenital Heart Disease.


Journal

NeoReviews
ISSN: 1526-9906
Titre abrégé: Neoreviews
Pays: United States
ID NLM: 101085360

Informations de publication

Date de publication:
01 08 2023
Historique:
medline: 2 8 2023
pubmed: 1 8 2023
entrez: 31 7 2023
Statut: ppublish

Résumé

Growth failure is common among infants with congenital heart disease (CHD), affecting approximately half of all infants with CHD. Achieving good growth is difficult secondary to both cardiac and noncardiac factors that affect energy expenditure and nutritional intake. Growth failure is associated with poor outcomes, including mortality, prolonged length of hospital stay, delayed cardiac surgery, postoperative complications, and neurodevelopmental delay. Clinical practice varies widely when it comes to how nutrition is managed in these infants, with varying approaches to enteral feeding initiation, advancement, and discontinuation. This variation persists despite several practice guidelines that have been created in recent years to guide nutritional care. Standardized feeding protocols have been proven to reduce growth failure and improve outcomes for this patient population. Centers and clinicians should be encouraged to adopt existing guidelines, or create their own from evidence-based literature, to improve growth and outcomes for infants with CHD.

Identifiants

pubmed: 37525313
pii: 192862
doi: 10.1542/neo.24-8-e492
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e492-e503

Informations de copyright

Copyright © 2023 by the American Academy of Pediatrics.

Auteurs

Audrey N Miller (AN)

Division of Neonatology, Department of Pediatrics, Ohio State University, Nationwide Children's Hospital, Columbus, OH.

Angelo Naples (A)

Ohio State University, Columbus, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH